CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a single arm, Phase II study using the combination of atezolizumab and bevicacizumab in women with advanced, recurrent or persistent endometrial...
Phase 2
Birmingham, Alabama, United States and 2 other locations
The purpose of this study is to compare pembrolizumab + adjuvant chemotherapy with placebo + adjuvant chemotherapy, with or without radiotherapy, wit...
Phase 3
Birmingham, Alabama, United States and 230 other locations
can be given alone or with cemiplimab to patients with ovarian cancer or cancer of the uterusThe study will also look at the levels...
Phase 1, Phase 2
Birmingham, Alabama, United States and 46 other locations
The purpose of this study is to evaluate the efficacy and safety of selinexor as a maintenance treatment in patients with p53 wt endometrial...
Phase 3
Birmingham, Alabama, United States and 125 other locations
This is a Phase 1, open-label, multicenter, dose-escalation and expansion study evaluating the safety, tolerability, PK, pharmacodynamics, and clinic...
Phase 1
Birmingham, Alabama, United States and 91 other locations
This is a multi-center, open-label, first-in-human Phase 1 study evaluating the anti-programmed death receptor 1 (anti-PD-1) antibody dostarlimab (al...
Phase 1
Birmingham, Alabama, United States and 144 other locations
The purpose of this study is to find out whether the study drug, LY3537982, is safe and effective in cancer patients who have a specific gen...
Phase 1, Phase 2
Birmingham, Alabama, United States and 50 other locations
Clinical trials
Research sites
Resources
Legal